EUROAPI completed the acquisition of Biano for €10m.

EUROAPI, a pharmaceutical company, completed the acquisition of BianoGMP, a biotechnology company, for €10m. “We are delighted to welcome the talented people of Biano. Biano has demonstrated a strong commitment to supporting clients with innovative oligonucleotide developments. I look forward to all that we will achieve together to sustainably meet clients’ and patients’ needs around the world through our complementarities,” Viviane Monges, EUROAPI CEO.